AUTHORS

Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

These 'Small Ball' Names Will Outperform the Market in 2019

Investors are already more focused on what lies ahead when Q1 results start in early April.

Divergence in U.S., Global Growth Prospects Will Demand Market's Attention

With weaker outlooks for growth in Europe and China, companies will look to the U.S. economy to remain buoyant.

4 Stocks to Like Amid the Earnings Deluge

An apparel giant, a carpet maker, a software firm and a provider of social entertainment apps turn in favorable results.

2 Value Stocks Buoyed by Recent Insider Buying

These 'off the radar' names that still sport reasonable valuations after 2019's equity rally.

2 Small-Cap Stocks That Are Still a Bargain

Despite the January rally, this biotech name and building materials firm still have further to rise.

Volatility Has Dropped Significantly Throughout the Equity Markets

I am becoming slightly more cautious on the overall investment landscape.

2 Small-Cap Biotech Stocks That Are on My Radar

These high risk/high reward oncology names look significantly undervalued, right now.

U.S. Immigration, Brexit, China Trade Talks Continue to Impact Markets

'This is not the beginning of the end, but it may be the end of the beginning.'

3 Undervalued Stocks That Insiders Are Still Buying

These are inexpensive names with nice dividends and insider buying.

These 2 Biotech Stocks Seem Significantly Undervalued

I would add to them on any significant dips in the market.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight